- Interventional cardiology in the year 1998 - stent, abciximab and what next?1998 | Faculty of Physical Education and Sport
- Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study: An open randomized multicentre study2011 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Pseudotrombocytopenie u nemocného s akutním STEMI spodní stěny léčeného abciximabemPublication without faculty affiliation
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS2004 | Third Faculty of Medicine
- Anticoagulation, antiaggregation, inhibitors IIb/IIIa or fibrinolytics prior to primary PCI?2004 | First Faculty of Medicine
- Access-site bleeding and radial artery occlusion in transradial primary percutaneous coronary intervention: influence of adjunctive antiplatelet therapy2016 | Faculty of Medicine in Pilsen
- Facilitated PCI in patients with ST-elevation myocardial infarction2008 | Third Faculty of Medicine
- Monoklonální protilátky v kardiologii - téma stále aktuálnější2015 | Third Faculty of Medicine
- 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial2009 | Third Faculty of Medicine
- Antiplatelet treatment of the ischemic heart disease2008 | Third Faculty of Medicine
- Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial2010 | Third Faculty of Medicine
- Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention A Formal Prospective Nonrandomized Substudy of the FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)2010 | Third Faculty of Medicine
- The 'PRAGUE' Trials series, part 22017 | Third Faculty of Medicine